Phase II Study to Investigate the Efficacy and Safety of BioCart™II in the Treatment of Symptomatic Cartilage Defects of the Femoral Condyle in Comparison With Microfracture
Latest Information Update: 28 May 2014
At a glance
- Drugs Autologous cultured chondrocytes (Primary)
- Indications Knee injuries
- Focus Therapeutic Use
- Sponsors ProChon Biotech
- 28 May 2014 New trial record